Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies – PR Newswire

Lilly to buy Kelonia Therapeutics to advance in vivo CAR-T cell therapies  PR Newswire

Source: news.google.com

Leave a Comment

Your email address will not be published. Required fields are marked *